Cargando…
Coumarin analogue 3-methyl-7H-furo[3,2-g]chromen-7-one as a possible antiparkinsonian agent
INTRODUCTION: Parkinson’s disease is the second most common neurodegenerative disease. Monoamine oxidase B inhibitors are used in the treatment of this disease concomitantly with levodopa or as monotherapy. Several substituted coumarins have shown activity as inhibitors of monoamine oxidase B. OBJEC...
Autores principales: | Olaya, María del Pilar, Vergel, Nadezdha Esperanza, López, José Luis, Viña, María Dolores, Guerrero, Mario Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Instituto Nacional de Salud
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7357371/ https://www.ncbi.nlm.nih.gov/pubmed/31584763 http://dx.doi.org/10.7705/biomedica.4299 |
Ejemplares similares
-
Radioiodination of 2,3-dimethyl-4H-furo[3,2-c]coumarin and biological evaluation in solid tumor bearing mice
por: Abd Elhalim, S.M., et al.
Publicado: (2015) -
Furo[3,2-c]coumarin-derived Fe(3+) Selective Fluorescence Sensor: Synthesis, Fluorescence Study and Application to Water Analysis
por: Sarih, Norfatirah Muhamad, et al.
Publicado: (2020) -
Furo[3,2-c]coumarins carrying carbon substituents at C-2 and/or C-3. Isolation, biological activity, synthesis and reaction mechanisms
por: Cortés, Iván, et al.
Publicado: (2020) -
Synthesis of the furo[2,3-b]chromene ring system of hyperaspindols A and B
por: Paterson, Danielle L, et al.
Publicado: (2015) -
7-(Hydroxymethyl)-2-(1-hydroxy-1-methylethyl)-4-methoxy-2,3-dihydro-5H-furo[3,2-g]chromen-5-one methanol hemisolvate
por: Li, Ru, et al.
Publicado: (2007)